Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework-Reference-Cited by-同舟云学术

Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework

Published:2021-01-25 Issue:4 Volume:73 Page:e1011-e1017
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Vekemans Johan¹,Hasso-Agopsowicz Mateusz¹^ORCID,Kang Gagandeep²,Hausdorff William P³,Fiore Anthony⁴,Tayler Elizabeth⁵,Klemm Elizabeth J⁶,Laxminarayan Ramanan⁷,Srikantiah Padmini⁸,Friede Martin¹,Lipsitch Marc⁹

Affiliation:

1. Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), Geneva, Switzerland

2. Division of Gastrointestinal Sciences, Christian Medical College, Vellore TN, India

3. PATH, Washington, District of Columbia, USA Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium

4. Centers for Disease Control and Prevention, Atlanta, Georgia, USA

5. Antimicrobial Resistance Division, World Health Organization (WHO), Geneva, Switzerland

6. Wellcome Trust, Bloomsbury, London, United Kingdom

7. Center for Disease Dynamics, Economics & Policy, Washington District of Columbia, USA

8. Bill and Melinda Gates Foundation, Seattle, Washington, USA

9. Harvard T. H. Chang School of Public Medicine, Boston, Massachusetts, USA

Abstract

This Action Framework identifies priority actions to prevent antimicrobial-resistant (AMR) through expanding the use of licensed vaccines, developing new vaccines that contribute to the prevention and control of AMR, and expanding knowledge about the impact of vaccines on AMR.

Funder

Bill and Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab062/36524468/ciab062.pdf

Reference24 articles.

1. Burden of six healthcare-associated infections on european population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study;Cassini;PLoS Med,2016

2. Antimicrobial resistance tackling the burden in the european union;ECDC.;Eur Cent Dis Prev Control,2019

3. Will 10 million people die a year due to antimicrobial resistance by 2050;de Kraker;PLoS Med,2016

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens;npj Vaccines;2024-08-18

2. WHO global research priorities for antimicrobial resistance in human health;The Lancet Microbe;2024-08

3. The Impact of Vaccination as a Strategy to Combat Bacterial Antimicrobial Resistance;Cureus;2024-07-31

4. Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens;BMC Microbiology;2024-07-27

5. Antimicrobial resistance in China across human, animal, and environment sectors – a review of policy documents using a governance framework;The Lancet Regional Health - Western Pacific;2024-07